Oncology | GileadPro

Contact our support teams

To access a range of services from medical information to adverse event reporting, please click here:

Contact us
T2_ONCOLOGY_1440x576

HCP resources (TNBC)

P3D_03_Bardia_900x600

Bardia A et al.

Sacitizumab govitecan in Metastatic Triple-Negative Breast Cancer
Read more
P3D_04_MOA_900x600

MoA video

Watch the proposed mechanism of action for TRODELVY
View now
P2D_03_AEs

Adverse event management summary

Gain a deeper understanding of the safety profile from TRODELVY and how to manage key adverse events
Download
P3D_02_DosingGuide _900x600

Dosing guide

Dosing and administration guide for TRODELVY
Coming soon

Patient resources (TNBC)

P3D_01_Englishbooklet

Patient booklet (English)

Provides patients with FAQs and information in English to support discussions with their healthcare professionals
Download
P3D_02_Arabicbooklet

Patient booklet (Arabic)

Provides patients with FAQs and information in Arabic to support discussions with their healthcare professionals
Download
P3D_03_SimplifiedChinese

Patient booklet (Simplified Chinese)

Provides patients with FAQs and information in Simplified Chinese to support discussions with their healthcare professionals
Download
P3D_04_TraditionalChinese

Patient booklet (Traditional Chinese)

Provides patients with FAQs and information in Traditional Chinese to support discussions with their healthcare professionals
Download

Our products

Oncology

TRODELVY

(sacituzumab govitecan)

PI CMI